Lars Holmkvist
Senior Vice President, Agilent
President, Diagnostics and Genomics Group
Lars Holmkvist is president of Agilent’s Diagnostics and Genomics Group. Holmkvist’s organization develops and produces cancer diagnostic tools, providing antibodies, reagents, scientific instruments and software to customers in pathology laboratories.
Holmkvist joined Agilent on June 21, 2012 when Dako, a Danish diagnostics company, was acquired by Agilent. Holmkvist has been president and CEO of Dako since 2009. Before joining Dako, he served as President Europe for Applied Biosystems where he was later promoted to President International with responsibility for all commercial operations outside the U.S. Before Applied Biosystems, Holmkvist was vice president at Medtronic (EMEA) Vascular & Cardiac Surgery.
Holmkvist brings more than 25 years of experience within the medical device and pharmaceutical industries where he has held several roles in marketing, sales and business management. He has lived and worked internationally for more than 15 years.
Holmkvist holds a degree in Economics from Handelshögskolan Sundsvall in Sweden.
Related Information
Executive images are intended for the news media use. They may not be altered in any way. If using informal photos, the hand gestures must be included in the image. Agilent Technologies must approve any commercial use of these images, please contact the Agilent Public Relations team for such permission.
 |
Download formal photo high resolution (.jpg, 275KB), low resolution (.jpg, 43KB) |
(40KB)